Ampio To Test Inhaled COVID-19 Treatment In India
21 Sep 21
Biotech, News, Penny Stocks, Health Care, Small Cap, Movers, Trading Ideas, General
Ampio Pharma Reports Received Approval From Drugs Controller General Of India To Begin AP-019 Phase 2 Study In India
21 Sep 21
Biotech, News, FDA, General
Ampio Pharmaceuticals (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced regulatory approval from the Drugs
EXCLUSIVE: Ampio's Ampion Shows Benefit In Late-Stage Knee Osteoarthritis Study
15 Sep 21
Biotech, News, Penny Stocks, Health Care, Exclusives, General
Ampio Pharmaceuticals Inc (NYSE: AMPE) has reported top-line results from the AP-013 Phase 3 trial evaluating the Company's intra-articular (IA) injection of Ampion in adults with pain due to severe osteoarthritis of the knee (OAK).
Earnings Scheduled For August 4, 2021
4 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Ampio To Present At October Scientific Conference Evidence Of Ampion's Role In Treating Lupus Nephritis, COVID-19
28 Jul 21
Biotech, News, Penny Stocks, Exclusives, General
Ampio Pharmaceuticals, Inc. (NYSE: AMPE), a biopharma developing immunotherapies for inflammatory conditions, is set to present data on lead drug Ampio at a scientific conference.